Drug class
Short-acting reversible acetylcholinesterase inhibitor; diagnostic cholinergic agent
Mechanism of action
Reversibly inhibits acetylcholinesterase, transiently increasing acetylcholine concentration at neuromuscular junctions and enhancing neuromuscular transmission.
General use cases
- Historically used as a diagnostic aid in suspected myasthenia gravis (Tensilon test) and for reversal assessment of non-depolarising neuromuscular blockade; availability is limited and diagnostic use has largely been superseded by antibody and electrophysiological testing
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
